Pluristem Therapeutics Overview
Pluristem Therapeutics Discounted Cash Flow
DCF Analysis for PSTI.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.11
Current Fair Value
$2.11
↑ 111.1% Upside
Undervalued by 111.1% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison